Clinical Research
The Philosophy of Rasayani Biologics believes firmly in capturing the Clinical Data in a most Scientific, Ethical and In Line with Global Regulatory requirements. This data forms the basis for obtaining the regulatory approvals and also in strategizing the product segmentation.
Majority of the drug candidates at RBPL are based on reverse pharmacology approach considerably reducing the risks in the later stages of drug development. This approach helps in reducing the overall time and resources required for taking the drug from Research to the market.
Clinical Research
Our clinical research department comprises a team of Physicians and Clinical Research professionals who work in collaboration with the scientists to confirm the leads.
A team of scientists trained in clinical pharmacology, practicing oncologists/Clinicians, subject matter experts, statisticians and regulatory experts help in designing the most suitable/optimum/feasible/ practically feasible protocol, which helps in smooth and successful conduct of the study. The implementation or conduct of the study is done by a team of experienced and qualified pharmacist, Clinical Research Professionals and statisticians in compliance to applicable Regulatory Guidelines and Good Clinical Practices (GCP). Company also has collaborations with several CROs whose help is taken on a case-to-case basis.
Team of Highly Experienced and Qualified Consultants
Expanding the Horizon of Partnerships
RBL– The Conclusion
Besides conducting Clinical Studies on in-house compounds, Rasayani Biologics is open to offer its expertise in the complete spectrum of Clinical Research including conduct of Clinical Trials.